Metropolitan Life Insurance Company (MetLife)’s Clover Health Investments CLOV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,041	Closed	-$18.6K	–	2470
2023 Q1	$18.6K	Sell	22,041 -1,863	-8%	-$2.04K	﹤0.01%	1918
2022 Q4	$22.2K	Hold	23,904	–	–	﹤0.01%	1960
2022 Q3	$40.6K	Hold	23,904	–	–	﹤0.01%	1601
2022 Q2	$51.2K	Buy	+23,904	New	+$63.5K	﹤0.01%	1496

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CLOV Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Clover Health Investments (CLOV) in Q2 2023, closing a stake of 22,041 shares — an estimated $18.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CLOV in Q2 2022 and held it in 4 quarters. The position peaked at $51.2K in Q2 2022. 145 funds tracked by Wall St. Rank hold CLOV as of Q2 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Clover Health Investments position as of Q2 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 22,041 Clover Health Investments shares in Q2 2023, an estimated $18.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Clover Health Investments in Q2 2022 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Clover Health Investments position peaked at $51.2K in Q2 2022.
145 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.